Effect of Combined Aerobic and Resisted Exercise in Breast Cancer Survivors

Effect of Combined Aerobic and Resisted Exercise in Breast Cancer Survivors: Upper Extremity Function, Quality of Life and Fitness Outcomes

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00877188

Enrollment

Registered

2009-04-07

Start date

2009-01-31

Completion date

2010-12-31

Last updated

2012-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Exercise, Physical Function

Keywords

breast cancer, exercise, upper extremity function, quality of life

Brief summary

The purpose of this study is to evaluate the effects of a combined aerobic and resistance exercise program in breast cancer survivors.

Detailed description

Cancer and cancer treatment side effects are associated with fatigue, pain, decreased cardiovascular fitness and muscle strength, and overall quality of life. Furthermore, cancer survivors are at increased risk for cancer recurrence and for secondary effect such as cardiovascular disease, diabetes, obesity, osteoporosis, and functional decline. Increase physical activity or exercise is proposed to overcome the negative psychological and physiological effects. Preliminary research evidence shows that exercise in cancer survivors improves quality of life, cardiorespiratory fitness, physical functioning, and decrease of fatigue. However, the best exercise mode and intensity has not been well established. Little is known regarding the long term effect. No study investigated impact of exercise for breast cancer survivors on upper extremity function, and correlation between fitness, upper extremity function and quality of life.

Interventions

OTHERexercise

supervised combined aerobic and progressive resistance training for 12 weeks

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* stage 0 to II breast cancer diagnosed within 5 years * complete adjuvant therapy \> 2 months, except hormone therapy * \> 18 years

Exclusion criteria

* disease in progress, recurrent, or metastasis * medical or musculoskeletal condition which resistance exercise is contraindicated * medication which may alter exercise response

Design outcomes

Primary

Measure	Time frame
muscle fitness, quality of life, upper extremity function	baseline, 12 weeks post exercise training and follow up 12 weeks

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026